Jhon Rivera-Monroy

7PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsBiologically active moleculesProteins and peptidesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 10, 2025
A Lactoferricin B/Buforin Chimeric Peptide Causes a Rapid, Selective, Prolonged Cytotoxic Effect and Induces Apoptosis in HPV18-Positive Cervical Cancer Cells.

Natalia Ardila-Chantré, Andrea Carolina Barragán-Cárdenas, Juan Esteban Reyes-Calderón

|Aug 28, 2025
Fluorescent Peptides Internalize HeLa Cells and Kill Multidrug-Resistant Clinical Bacterial Isolates.

Daniel Castellar-Almonacid, Kelin Johana Cuero-Amu, Jose David Mendoza-Mendoza

|Jul 25, 2025
Non-steroidal anti-inflammatory drugs conjugated to a synthetic peptide exhibit in vitro cytotoxic activity against cervical cancer and melanoma cells.

Daniel Alejandro Castellar-Almonacid, Andrea Carolina Barragán-Cárdenas, Karla Geraldine Rodríguez-Mejia

|Jun 23, 2025
Exploring New Biomarkers for Detecting Whey Adulteration in Milk: Synthesis and Characterization of Caseinomacropeptide-Derived Peptides.

David Alexander Parada-Suárez, Jose David Mendoza-Mendoza, Kevin Andrey Huertas-Ortiz

|Jan 14, 2021
Endoplasmic reticulum membrane receptors of the GET pathway are conserved throughout eukaryotes.

Lisa Yasmin Asseck, Dietmar Gerald Mehlhorn, Jhon Rivera Monroy

|Aug 23, 2020
The Molecular Basis and Biologic Significance of the β-Dystroglycan-Emerin Interaction.

Wendy Lilián Gómez-Monsivais, Feliciano Monterrubio-Ledezma, Jazmin Huerta-Cantillo

Pageof 2

Frequent Collaborators

4 joint publications

Javier García-Castañeda

4 joint publications

Zuly Jenny Rivera-Monroy

3 joint publications

Jose David Mendoza-Mendoza

2 joint publications

Blanche Schwappach